Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion

PHASE4RecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

August 30, 2017

Primary Completion Date

July 1, 2026

Study Completion Date

September 1, 2026

Conditions

Hip Fractures

Interventions

DRUG

Tranexamic Acid (TXA)

Tranexamic acid is an antifibrinolytic used to control bleeding

DRUG

Saline solution

Saline solution is used as the placebo comparator

Trial Locations (1)

RECRUITING

ProMedica Toledo Hospital, Toledo

All Listed Sponsors

lead

Gregory M Georgiadis MD

OTHER